Aaron Mangold News Today

This week, we speak with individuals who are committed to tearing down barriers in health care through representation.

Response rates in a phase 2 trial of a novel therapy for skin-predominant dermatomyositis were favorable in patients failed by at least one prior standard therapy, prompting plans for a phase 3 trial.

Dr Michael Goldman, 67, of Erasme Hospital in Brussels, was diagnosed with lymphoma - cancer of the immune system - last summer.

An unusual incident at a hockey game may have been lifesaving for one staff member with a suspicious skin mole.